HLCL-61 hydrochloride
| CAS No. | 1158279-20-9 | Cat. No. | BCP20660 |
| Name | HLCL-61 hydrochloride | ||
| Synonyms | HLCL61 hydrochloride; HLCL-61 HCl; HLCL61 HCl; HLCL 61 HCl; HLCL 61 hydrochloride; | ||
| Formula | C23H25ClN2O | M. Wt | 380.91 |
| Description | HLCL-61 is a potent and selective PRMT5 inhibitor for treatment of acute myeloid leukemia. HLCL-61 resulted in significantly increased expression of miR-29b and consequent suppression of Sp1 and FLT3 in AML (acute myeloid leukemia) cells. As a result, significant antileukemic activity was achieved. The increased PRMT5 activity enhanced AML growth in vitro and in vivo while PRMT5 downregulation reduced it. In AML cells, PRMT5 interacted with Sp1 in a transcription repressor complex and silenced miR-29b preferentially via dimethylation of histone 4 arginine residue H4R3. | ||
| Pathways | Epigenetics | ||
| Targets | Histone Methyltransferase | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.